NIH BRAIN Initiative Publication Roundup – late February 2016

Image
NIH logo

Widespread delivery of genes across the blood brain barrier…light-activated glutamate receptors become more specialized, used in vivo for first time…manipulations of intraocular pressure are used to measure intracranial pressure…researchers discover new types of retinal ganglion cells.

Designing a more efficient way to transfer genes to neurons throughout the brain

Small, harmless viruses called adeno-associated viruses (AAV) have been used over the past two decades to transport specific genes into the nuclei of cells. This delivery system can be used clinically to carry functional copies of genes into cell nuclei in individuals with genetic diseases. Clinical applications have been hindered by the inability of current AAVs to cross the blood brain barrier (BBB) and achieve widespread transfer across the brain. Caltech researchers, led by BRAIN Initiative grantee Dr. Viviana Gradinaru, created millions of genetic variants of AAV9, the most effective AAV for gene transfer. They then created an assay, described in a recent issue of Nature Biotechnology, to test the efficiency of these variants and found one, AAV-PHP.B, which crosses the BBB and transfers genes with 40 times the efficiency of AAV9.

Image
Genetic manipulation of the gene-delivery virus AAV9 resulted in the creation of AAV-PhP.B, which is 40 times more effective than AAV9 at transferring genes throughout the entire brain.
Genetic manipulation of the gene-delivery virus AAV9 resulted in the creation of AAV-PhP.B, which is 40 times more effective than AAV9 at transferring genes throughout the entire brain.

Researchers develop toolkit of light-activated glutamate receptors and demonstrate their use in vivo

Optogenetics—the ability to use light to manipulate the activity of neurons with genetically expressed light sensitive ion channels—is a powerful technique for mapping neural circuits and determining the roles populations of neurons play in a variety of behaviors. To understand the subcellular, molecular basis of brain function, however, requires the manipulation of natively expressed signaling proteins. A few years ago, BRAIN Initiative grantee Dr. Ehud Isaacoff and his UC Berkeley colleagues developed a series of light-activated glutamate receptors (LiGluR). The researchers describe in a recent Frontiers in Molecular Neuroscience paper how they have further engineered their LiGluRs based on known properties of glutamate receptor function to make designer variants for specific functions. In addition, the new paper reports the first in vivo use of the LiGluRs, which they demonstrated in mice. 

Image
(A) LiGluR-GFP expression in a cultured hippocampal neuron visualized with confocal imaging. (B) One variant of LiGluR, L-MAGo, allows for optical depolarization in a bistable fashion: 375 nm light (violet bar) depolarizes the cells, which results in an increase in action potential firing, while illumination with 480 nm light (green bar) readily reverses the effect. (C) Another variant, L-MAGo460, allows optical control of neuronal firing with light of a single wavelength, 460 nm (blue bar).
(A) LiGluR-GFP expression in a cultured hippocampal neuron visualized with confocal imaging. (B) One variant of LiGluR, L-MAGo, allows for optical depolarization in a bistable fashion: 375 nm light (violet bar) depolarizes the cells, which results in an increase in action potential firing, while illumination with 480 nm light (green bar) readily reverses the effect. (C) Another variant, L-MAGo460, allows optical control of neuronal firing with light of a single wavelength, 460 nm (blue bar).

Modulating intraocular pressure helps researchers non-invasively measure intracranial pressure

Changes in intracranial pressure (ICP) are associated with several serious medical conditions, including traumatic brain injury, stroke, brain tumors, and glaucoma. Current techniques for measuring ICO are highly invasive, requiring either a spinal tap or a needle inserted into the brain. BRAIN Initiative grantee Dr. Craig Forest of the Georgia Institute of Technology and colleagues have designed, fabricated, and tested a system for measuring ICP non-invasively. The researchers’ system, described in a recent issue of PLOS One, takes measure pulsation of a blood vessel called the central retinal vein. This vein visibly pulsates when ICP and intraocular pressure (IOP) are normal. When ICP is high or IOP is low, it does not pulsate. The researchers manipulated IOP with injections of small volumes of liquid into the eye until the retinal vein stopped pulsating. The volume needed to achieve this was used to indicate ICP. More work is needed to make the measurement accurate enough for the clinic.

Image
A syringe pump injects or withdraws fluid from the eye via a needle inserted into the anterior chamber through the peripheral cornea, while a second needle connected to a pressure transducer records intraocular pressure (IOP). This procedure gives an indirect measurement of intracranial pressure (ICP).
A syringe pump injects or withdraws fluid from the eye via a needle inserted into the anterior chamber through the peripheral cornea, while a second needle connected to a pressure transducer records intraocular pressure (IOP). This procedure gives an indirect measurement of intracranial pressure (ICP).

 

2-photon calcium imaging reveals functionally diverse retinal ganglion cells in mouse retina

In the visual system, photoreceptors transmit visual information to bipolar cells, which provide input to a variety of retinal ganglion cells (RGCs). Each type of RGC extracts specific features of the visual world for transmission to the brain. Previous experiments examining the anatomy of RGCs and their electrical responses to different kinds of visual stimuli have suggested that there are 15-20 unique types of RGC, each with a unique function. BRAIN Initiative grantee Dr. Thomas Euler, of the University of Tübingen in Germany, and his colleagues, used 2-photon calcium imaging to measure responses of more than 11,000 RGCs from 50 mouse retinas to a variety of visual stimuli. The researchers fed the resulting imaging data, which was recently published in Nature, into an unsupervised machine-learning algorithm that was designed to classify all of the cells into unique types. They discovered a minimum of 32, but possibly up to 49, separate RGC types.

Image
A machine-learning algorithm helped scientists classify 11,000 retinal ganglion cells in to 49 unique functional types based on their responses–measured with 2-photon calcium imaging–to a variety of stimuli that included “chirping” or flashing full-field screens, moving bars, and full-field screens of different colors.
A machine-learning algorithm helped scientists classify 11,000 retinal ganglion cells in to 49 unique functional types based on their responses–measured with 2-photon calcium imaging–to a variety of stimuli that included “chirping” or flashing full-field screens, moving bars, and full-field screens of different colors.

Latest from The BRAIN Blog

The BRAIN Blog covers updates and announcements on BRAIN Initiative research, events, and news. 

Hear from BRAIN Initiative trainees, learn about new scientific advancements, and find out about recent funding opportunities by visiting The BRAIN Blog.

Image
black and white image of people working on laptops at a counter height table on stools at the annual BRAIN meeting